ReleaseWire Connect

According to the research report, the opportunity offered in this market will reach US$1.1 bn by 2017 end. Progressing at a CAGR of 11.90% during the period from 2017 to 2022, the market is expected to rise to US$2.05 bn by the end of the period of the forecast.

Transparency Market Research (TMR) has announced the publication of a new market research report on the preimplantation genetic diagnosis. Statistics mentioned in the report suggest that the global preimplantation genetic diagnosis market was valued at US$77.2 million in 2013 and is expected to reach US$118.0 million by 2020, growing a CAGR of 6.28% from 2014 to 2020. The report, titled "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", offers an in-depth understanding of the global preimplantation genetic diagnosis market, its growth drivers, market restraints, and potential growth opportunities in the coming future.

Rheumatology is the multidisciplinary approach towards the diagnosis and treatment of the various rheumatic disease which includes clinical problems in joints, soft tissues, heritable connective tissue disorders, vasculitis, and autoimmune diseases. Rheumatic disease is associated with inflammation that affects the bones, tendons, ligaments, and sometimes organs.

The global cardiopulmonary stress testing systems market is driven by several crucial factors. Diagnosis of proper functioning of the heart remains the first line of treatment that helps physicians to assess the health status of patients who are at risk of cardiovascular diseases. A stress test helps physicians to evaluate the heart functioning based on several parameters such as blood pressure, heart rhythm, breathing, etc. and is performed typically on treadmill or cycle. For instance, stress echocardiography involves capturing ultrasound images of heart when the heart reaches peak level, which gives insights about the supply of blood and oxygen from the heart while performing an exercise. Alternately, an imaging test is conducted if the patient is unable to walk on the treadmill or cycle or if the exercise stress test does not give satisfactory results to diagnose the cause of heart problem

A featured report from Transparency Market Research (TMR), titled "Orthodontic Equipment and Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020", offers a 360-degree view of the market. According to this report, the global orthodontic equipment and consumables market will expand at an 8.80% CAGR during the forecast period from 2014 to 2020. In 2013, the global orthodontic equipment and consumables market was worth US$6.1 bn and by 2020, the market is projected to be worth US$11.0 bn. The global orthodontic equipment and consumables market is driven by the rising popularity of cosmetic dentistry, technological advancements in orthodontic treatment technologies, rising prevalence of malocclusion, and the expanding dental tourism market.

A market study on the global digital pathology systems market, recently published by Transparency Market Research (TMR), estimates this market to rise at a healthy CAGR of 11.0% over the period from 2014 to 2020 and reach a value US$492.8 mn by the end of the forecast period. The research report, titled "Digital Pathology Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," states that the worldwide market for digital pathology systems attained a value of US$229 mn in 2013.

The research report states that the global telemedicine market was valued at US$14.3 bn in 2014 and is estimated to reach US$36.3 bn by 2020, growing at a CAGR of 14.30% from 2014 to 2020.The global telemedicine market has been witnessing a boom due to the growing demand for privacy, increasing government expenditure, supportive reimbursement policies, and rise in the demand for personal healthcare. In addition to this, the efforts of global telemedicine market players to tap into the unmet medical needs in remote places and the increasing patient pool in rural areas will also help the proliferation of this market.

The Latin America home healthcare market is exhibiting a CAGR of 8.7% from 2014 to 2020. The market was valued at US$9.8 bn in 2013 and is expected to be valued at US$17.5 bn in 2020. The statistical data has been compiled in a research report released by Transparency Market Research, titled "Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services: Rehabilitation, Telehealth and Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare Services) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020".

According to a TMR analyst, "In 2013, the global market for non-invasive prenatal market was worth US$0.5 bn. This figure is anticipated to rise to a revenue of US$2.38 bn by the end of 2022, with a significantly growing CAGR of 17.50% from 2014 to 2022." On the basis of type, the segment is estimated to be led by NIFTY, Verifi, Bambni, Panorama that are being estimated to emerge stronger than before in the market, replacing the former leader. In 2013, MaterniT20 PLUS segment held the maximum shares of 36.1% in the global market for NIPT.

The Middle East and Africa defibrillators market consists of 3-4 major players. Almost each leading player is based outside the region and functions in the region with the help of distribution arrangements. A latest report by Transparency Market Research titled, "Defibrillators Market - Middle East and Africa Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 – 2020,"talks about the dynamic and fast-growing structure of the Middle East and Africa defibrillators market and offers a statistically driven market forecasts.